{"source": "PMC", "date": "20210103", "key": "pmc.key", "infons": {}, "documents": [{"id": "5502740", "infons": {"license": "author_manuscript"}, "passages": [{"offset": 0, "infons": {"article-id_doi": "10.1097/FPC.0000000000000284", "article-id_manuscript": "NIHMS870773", "article-id_pmc": "5502740", "article-id_pmid": "28542097", "fpage": "247", "issue": "7", "kwd": "Anthracycline cardiotoxicity genome-wide association study pathway analysis", "license": "\n          This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.\n        ", "lpage": "254", "name_0": "surname:Wells;given-names:Quinn S.", "name_1": "surname:Veatch;given-names:Olivia J.", "name_10": "surname:Glazer;given-names:Andrew M.", "name_11": "surname:Bersell;given-names:Kevin R.", "name_12": "surname:Van Driest;given-names:Sara L.", "name_13": "surname:Karnes;given-names:Jason H.", "name_14": "surname:Blair;given-names:Marcia A.", "name_15": "surname:Lagrone;given-names:Lore W.", "name_16": "surname:Su;given-names:Yan R.", "name_17": "surname:Bowton;given-names:Erica A.", "name_18": "surname:Feng;given-names:Ziding", "name_19": "surname:Ky;given-names:Bonnie", "name_2": "surname:Fessel;given-names:Joshua P.", "name_20": "surname:Lenihan;given-names:Daniel J.", "name_21": "surname:Fisch;given-names:Michael J.", "name_22": "surname:Denny;given-names:Joshua C.", "name_23": "surname:Roden;given-names:Dan M.", "name_3": "surname:Joon;given-names:Aron Y.", "name_4": "surname:Levinson;given-names:Rebecca T.", "name_5": "surname:Mosley;given-names:Jonathan D.", "name_6": "surname:Held;given-names:Elizabeth P.", "name_7": "surname:Lindsay;given-names:Chase S.", "name_8": "surname:Shaffer;given-names:Christian M.", "name_9": "surname:Weeke;given-names:Peter E.", "section_type": "TITLE", "type": "front", "volume": "27", "year": "2018"}, "text": "Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults", "sentences": [], "annotations": [], "relations": []}, {"offset": 113, "infons": {"section_type": "ABSTRACT", "type": "abstract_title_1"}, "text": "Background", "sentences": [], "annotations": [], "relations": []}, {"offset": 124, "infons": {"section_type": "ABSTRACT", "type": "abstract"}, "text": "Anthracyclines are important chemotherapeutic agents, but their use is limited by cardiotoxicity. Candidate gene and genome-wide studies have identified putative risk loci for overt cardiotoxicity and heart failure, but there has been no comprehensive assessment of genomic variation influencing the intermediate phenotype of anthracycline-related changes in left ventricular (LV) function. The purpose of this study was to identify genetic factors influencing changes in LV function after anthracycline chemotherapy.", "sentences": [], "annotations": [], "relations": []}, {"offset": 642, "infons": {"section_type": "ABSTRACT", "type": "abstract_title_1"}, "text": "Methods", "sentences": [], "annotations": [], "relations": []}, {"offset": 650, "infons": {"section_type": "ABSTRACT", "type": "abstract"}, "text": "We conducted a genome-wide association study (GWAS) of change in LV function after anthracycline exposure in 385 subjects identified from BioVU, a resource linking DNA samples to de-identified electronic medical record data. Variants with p-values <1x10-5 were independently tested for replication in a cohort of 181 anthracycline-exposed subjects from a prospective clinical trial. Pathway analysis was performed to assess combined effects of multiple genetic variants.", "sentences": [], "annotations": [], "relations": []}, {"offset": 1124, "infons": {"section_type": "ABSTRACT", "type": "abstract_title_1"}, "text": "Results", "sentences": [], "annotations": [], "relations": []}, {"offset": 1132, "infons": {"section_type": "ABSTRACT", "type": "abstract"}, "text": "Both cohorts were middle-aged adults of predominantly European descent. Among 11 candidate loci identified in discovery GWAS, one single nucleotide polymorphism (SNP) near PR Domain Containing 2, With ZNF Domain (PRDM2), rs7542939, had a combined p-value of 6.5x10-7 in meta-analysis. Eighteen Kyoto Encyclopedia of Gene and Genomes (KEGG) pathways showed strong enrichment for variants associated with the primary outcome. Identified pathways related to DNA repair, cellular metabolism, and cardiac remodeling.", "sentences": [], "annotations": [], "relations": []}, {"offset": 1647, "infons": {"section_type": "ABSTRACT", "type": "abstract_title_1"}, "text": "Conclusions", "sentences": [], "annotations": [], "relations": []}, {"offset": 1659, "infons": {"section_type": "ABSTRACT", "type": "abstract"}, "text": "Using genome-wide association we identified a novel candidate susceptibility locus near PRDM2. Variation in genes belonging to pathways related to DNA repair, metabolism, and cardiac remodeling may influence changes in LV function after anthracycline exposure.", "sentences": [], "annotations": [], "relations": []}, {"offset": 1920, "infons": {"section_type": "INTRO", "type": "title_1"}, "text": "INTRODUCTION", "sentences": [], "annotations": [], "relations": []}, {"offset": 1933, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Anthracyclines are important chemotherapeutic agents, but their use is limited by cardiotoxicity that characteristically manifests as progressive systolic dysfunction. Many mechanisms for cardiotoxicity have been proposed, including production of reactive oxygen species and alterations in anthracycline metabolism and transport. More recent data suggest anthracycline-mediated inhibition of topoisomerases, in particular, topoisomerase IIbeta and mitochondrial topoisomerase I, are central to cardiotoxicity, producing double strand DNA breaks, activation of apoptotic pathways, and ultimately impaired mitochondrial function and decreased mitochondrial biogenesis. Anthracyclines also impair sarcomere maintenance, disrupt cell survival signaling, and impair cellular fatty acid metabolism.", "sentences": [], "annotations": [], "relations": []}, {"offset": 2726, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Anthracycline cardiotoxicity is dose-dependent at a population level, but substantial inter-individual variability makes it difficult to predict which patients will be affected even when cumulative exposure and clinical parameters are known, indicating influences beyond dose and known risk factors play a substantial role in susceptibility. Several genetic variants influencing development of overt cardiotoxicity and heart failure have been implicated by candidate gene analyses and genome wide association studies (GWAS), primarily in childhood cancers. Nevertheless, known genetic factors do not explain all the observed variability in susceptibility.", "sentences": [], "annotations": [], "relations": []}, {"offset": 3382, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Common definitions of anthracycline-induced cardiotoxicity require a significant decrease in cardiac function or clinical evidence of cardiac insufficiency. However, dichotomous classifications have limitations, as more subtle effects may be meaningful, and even severe cardiac dysfunction can be asymptomatic. Indeed, continuous measures of left ventricular (LV) structure and function in the general population are both heritable and associated with important cardiovascular outcomes. The quantitative change in LV function is an intermediate phenotype of anthracycline-induced cardiotoxicity, and, importantly, early reductions in this metric are associated with later development of overt cardiotoxicity. However, the genomic influences on anthracycline-induced alterations in cardiac function, particularly in adults, have not been studied in a genome-wide, unbiased fashion. Understanding the genomics of this intermediate phenotype may help characterize quantitative, mechanistic aspects of cardiotoxicity and form the basis for identification of at-risk individuals and implementation of measures to minimize or prevent toxicity.", "sentences": [], "annotations": [], "relations": []}, {"offset": 4520, "infons": {"section_type": "METHODS", "type": "title_1"}, "text": "METHODS", "sentences": [], "annotations": [], "relations": []}, {"offset": 4528, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Study Populations", "sentences": [], "annotations": [], "relations": []}, {"offset": 4546, "infons": {"section_type": "METHODS", "type": "title_3"}, "text": "Discovery GWAS", "sentences": [], "annotations": [], "relations": []}, {"offset": 4561, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The discovery dataset was generated from BioVU, a Vanderbilt resource linking DNA samples to de-identified electronic medical records (EMR). The development, implementation, and use of BioVU as a platform for discovery has been previously described. Briefly, BioVU contains over 215,000 DNA samples extracted from blood leftover after routine clinical care at Vanderbilt University Medical Center.", "sentences": [], "annotations": [], "relations": []}, {"offset": 4959, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Subjects with anthracycline exposure were identified using key word searches and automated queries of procedure codes (see Text, Supplemental Digital Content 1). Assessments of left ventricular ejection fraction (LVEF) were extracted retrospectively from clinical reports of imaging modalities including transthoracic echocardiography, radionuclide ventriculography, single-photon emission computed tomography, cardiac computed tomography, and cardiac magnetic resonance imaging. Imaging was performed at the discretion of providers as clinically indicated. Cumulative anthracycline dose, pre- and post-chemotherapy LVEF values, and pre-chemotherapy clinical covariates were extracted by manual review of the EMR. Subjects were excluded if they were not exposed to anthracycline, had no measures of LVEF after chemotherapy initiation, or had insufficient EMR documentation of covariates. LVEF measurements acquired during acute illness (e.g., sepsis) were excluded. Anthracycline exposures considered were doxorubicin, doxorubicin liposomal, daunorubicin, idarubicin, and epirubicin. Doses were converted to doxorubicin equivalents (see Text, Supplemental Digital Content 1), indexed to body surface area, and expressed as doxorubicin equivalents mg/m2. In a minority of cases, baseline LVEF and cumulative anthracycline dose were not documented in subjects with otherwise complete information. These data were imputed using multiple imputation implemented in SPSS statistical software version 20 (IBM Corp., Armonk, NY).", "sentences": [], "annotations": [], "relations": []}, {"offset": 6481, "infons": {"section_type": "METHODS", "type": "title_3"}, "text": "Replication", "sentences": [], "annotations": [], "relations": []}, {"offset": 6493, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The replication dataset was drawn from subjects enrolled in the \"Patients undergoing anthracycline-based chemotherapy to assess the effectiveness of using biomarkers to detect and identify cardiotoxicity and describe treatment\" (PREDICT) study (ClinicalTrials.gov number NCT01311843). PREDICT is a multicenter study with coordinating sites at MD Anderson Cancer Center, Houston, TX and Vanderbilt University Medical Center, Nashville, TN. The study protocol was approved by the Institutional Review Boards of both institutions. At enrollment, subjects were age >=18 years, had an LVEF >=50%, and were starting a new course of chemotherapy that included an anthracycline. Prior chemotherapy exposure, including anthracyclines, was not an exclusion criteria. Subjects underwent serial assessment of cardiac function with transthoracic echocardiography at baseline, 6 and 12 months after initiation of chemotherapy, or if indicated clinically. To ensure no subjects were included in both discovery and replication populations, only subjects from outside Vanderbilt were considered for inclusion.", "sentences": [], "annotations": [], "relations": []}, {"offset": 7592, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Genotyping and Imputation", "sentences": [], "annotations": [], "relations": []}, {"offset": 7618, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "BioVU subjects were genotyped in the Vanderbilt Technologies for Advanced Genomics (VANTAGE) Core using the Illumina Omni 1-Quad platform. Pre-imputation quality control filters were applied at the sample level (exclusion criteria: call rate <98%, sex discrepancy, relatedness, duplicate discordance, and HapMap discordance) and single nucleotide polymorphism (SNP) level (exclusion criteria: call rate <98%, replicate discordance, and Mendelian errors). Genotypes were imputed to 1000 Genomes Phase 1 version 3 (April 19, 2012) using IMPUTE2 software and reference panels from all 1000 Genomes populations, and alleles with confidence >0.9 were retained (see Text, Supplemental Digital Content 1). Candidate SNPs with p-values <1x10-5 in discovery were genotyped in the replication cohort using the Sequenom MassArray genotyping system. Quality control parameters included sample genotyping efficiency >90% and SNP genotyping efficiency >95%.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8565, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Statistical Analysis", "sentences": [], "annotations": [], "relations": []}, {"offset": 8586, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The primary outcome was maximal change in LVEF from pre-chemotherapy measurement. This intermediate phenotype was chosen because changes in this parameter are used in clinical practice to define and detect anthracycline cardiotoxicity. If LVEF increased from baseline, the maximum positive change and cumulative chemotherapy dose up to that time point was recorded. If LVEF decreased from baseline the maximum negative change and cumulative chemotherapy to that time point was recorded. If both positive and negative changes from baseline LVEF were present, the maximum negative change and cumulative chemotherapy to that time point were recorded.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9234, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "In discovery GWAS, multiple linear regression, implemented in PLINK, was used to test for association between SNPs and change in LVEF adjusting for age, gender, baseline LVEF, cumulative anthracycline dose at time of outcome LVEF, follow-up time from start of anthracycline, number of cardiac risk factors (hypertension, diabetes, coronary artery disease, dyslipidemia, smoking), and concomitant trastuzumab. All subjects were included regardless of ancestry, and principal components one and two (which explained 28% of the variance in the genetic data) were included to adjust for possible population stratification (see Figures, Supplemental Digital Content 3 and 4). Only SNPs with minor allele frequency (MAF) >= 0.05 were included in analyses. A priori genome-wide significance was defined as 5x10-8. Lead SNPs from loci with p-values <1x10-5 in the discovery GWAS were tested for association in the replication cohort. Analysis again utilized multiple linear regression with clinical covariates as in discovery, with the exception of the substitution of self-reported ancestry for principal components. Analysis was conducted using the R statistical package. The combined p-value from the discovery GWAS and replication for each SNP was determined using inverse variance based meta-analysis (see Text, Supplemental Digital Content 1).", "sentences": [], "annotations": [], "relations": []}, {"offset": 10583, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Pathway-based Genome-wide Association Study", "sentences": [], "annotations": [], "relations": []}, {"offset": 10627, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Pathway analysis was performed with the Pathway Analysis by Randomization Incorporating Structure (PARIS) software package(23). SNPs were first assigned to gene boundaries based on genomic location. Genes, in turn, were assigned to functional networks, which were tested for overrepresentation of SNPs that were observed to be nominally associated with change in LVEF in the single-SNP GWAS. Since the goal of pathway-based analysis was to extend on the single-SNP GWAS and identify cumulative effects on change in LVEF that related to multiple SNPs, with individually smaller effects, we set a less stringent threshold and significant SNPs were defined as those with p-values <= 0.05 from the discovery GWAS.Biological pathways were defined based on the KEGG Pathway Database.(24) A total of 290 KEGG pathways were evaluated for overrepresentation of SNPs significantly associated with change in LVEF. To determine p-values for overall association of pathways, permutation tests were conducted comparing pathways defined in the KEGG database to random pathways generated from regions across the genome having similar linkage disequilibrium (LD) structure (as predicted based on control individuals of European ancestry available in the HapMap population). We chose to generate random pathways for permutation tests using the LD structure predicted for individuals of European ancestry as the majority of the analysis dataset (~84%) that was evaluated in the single-SNP GWAS, from which the p-values for SNPs were derived, represented this ancestral group. The number of SNPs significantly associated with change in LVEF assigned to each evaluated KEGG pathway were compared to the number of significantly associated SNPs in 3,500 randomly generated pathways. Based on this number of permutation tests, we chose a stringent significance threshold of p<2.86x10-4 for pathway-based results, which corresponded to a false discovery rate-corrected p-value of <= 0.05.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12596, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "To better understand the relationship of associated pathways to risk for change in LVEF, pathways that were significantly associated were further subjected to permutation-based investigations to identify 'core' genes driving overall pathway associations. 'Core' genes were defined as genes whose p-value in the context of the biological pathway was p<0.001.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12962, "infons": {"section_type": "RESULTS", "type": "title_1"}, "text": "RESULTS", "sentences": [], "annotations": [], "relations": []}, {"offset": 12970, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "Discovery and Replication Cohort Identification", "sentences": [], "annotations": [], "relations": []}, {"offset": 13018, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "Search of BioVU identified 385 subjects with anthracycline exposure, measures of LVEF, and available DNA samples (see Figure, Supplemental Digital Content 4). Subjects were median age 52 years [interquartile range (IQR) 40 to 61 years], 58% female, and 88% white. Non-Hodgkin's lymphoma and breast cancer were the most common malignancies. Median baseline LVEF was 64% [IQR 60 to 68%], and the median change in LVEF from baseline was -6% [IQR 0 to -12%] with a range of 22 to -47% (Figure 1A). The median anthracycline exposure (doxorubicin equivalents) was 240 mg/m2 [IQR 180 to 300 mg/m2]. The median time from baseline LVEF to anthracycline exposure was 6 days [IQR 2 to 13 days], and median follow-up between chemotherapy initiation and outcome LVEF was 348 days [IQR 122 to 755 days] (Table 1). Radionuclide ventriculography and transthoracic echocardiography accounted for over 95% of both pre-chemotherapy (74% radionuclide ventriculography; 24% transthoracic echocardiography) and outcome (50% radionuclide ventriculography; 46% transthoracic echocardiography) LVEF observations. Baseline LVEF and cumulative aanthracycline dose were imputed for 74 (19%) and 2 (0.5%) subjects respectively.", "sentences": [], "annotations": [], "relations": []}, {"offset": 14225, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "The replication cohort included 181 PREDICT subjects with adequate DNA samples and complete phenotype data (see Figure, Supplemental Digital Content 5). Subjects were median age 53 years [IQR 45 to 61 years], 87% female, and 84% white. Breast cancer was the most common malignancy. The median baseline LVEF was 64% [IQR 60 to 68%], and the median change in LVEF was -4% [IQR 3 to -9%] with a range of 16 to -28% (Figure 1B). The median anthracycline dose was 224 mg/m2 [IQR 60 to 241 mg/m2], with a median follow-up from start of chemotherapy of 217 days [IQR 180 to 364 days] (Table 2), and XX subjects had prior exposure to chemotherapy", "sentences": [], "annotations": [], "relations": []}, {"offset": 14870, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "Discovery GWAS and Replication", "sentences": [], "annotations": [], "relations": []}, {"offset": 14901, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "After imputation and quality control, 4,429,986 markers were included in the discovery GWAS. A single locus on chromosome 1 (1p32.1) reached genome-wide significance with a p-value of 2.7x10-8 for the lead SNP rs10443221, which conferred protection (beta=4.11; standard error 0.74) from cardiotoxicity (i.e., change in LVEF was 4.11 points higher for each alternate allele). The nearest characterized gene is CYP2J2. Ten other loci had p-values <1.0x10-5, including rs7542939 at 1p36.21 (Figure 2; see Figure, Supplemental Digital Content 6 and 7). Lead SNPs from all 11 loci were carried forward for testing in the replication cohort. Results of association testing for discovery and replication are summarized in Table 3. One locus, 1p36.21, successfully replicated with the lead SNP rs7542939 having a p-value of 0.01. This SNP had an overall MAF of 0.15 and conferred increased risk (overall beta=-3.82; standard error 0.77) for a decrease in LVEF. The combined p-value from meta-analysis for this SNP was 6.5x10-7. The nearest annotated gene, PRDM2, is approximately 40 kilobases upstream and encodes an H3K9 methyltransferase that regulates gene expression through modification of chromatin at target genes promoters. No association between SNP rs10443221 and change in LVEF was observed in the replication cohort (beta=-1.2; standard error 0.80; p=0.14).", "sentences": [], "annotations": [], "relations": []}, {"offset": 16270, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "Pathway-based Genome-Wide Association Study", "sentences": [], "annotations": [], "relations": []}, {"offset": 16314, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "There were 18 KEGG pathways with strong evidence (p<2.86x10-4) of enrichment for SNPs associated with changes in LVEF (see Table, Supplemental Digital Content 8). Five pathways were directly related to cellular metabolism and mitochondrial function, including: synthesis and degradation of ketone bodies, ubiquinone and other terpenoid-quinone biosynthesis, D-Glutamine and D-glutamate metabolism, PPAR signaling pathway, and aminoacyl-tRNA biosynthesis (whose association was driven by genes coding for mitochondrial aminoacyl-tRNA synthetases). Associations of five additional pathways, N-glycan biosynthesis, glycosaminoglycan degradation, Wnt signaling, notch signaling, and axon guidance were driven by genes previously implicated in cardiac remodeling. Also enriched was the DNA repair pathway base excision and repair.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17143, "infons": {"section_type": "DISCUSS", "type": "title_1"}, "text": "DISCUSSION", "sentences": [], "annotations": [], "relations": []}, {"offset": 17154, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "We conducted a GWAS and pathway analysis of change in LVEF after exposure to anthracycline chemotherapy. Our GWAS results suggest a novel candidate susceptibility locus at chromosome 1p36.21 near PRDM2, and pathway analysis highlights the multifactorial nature of anthracycline cardiotoxicity and points toward processes involved in cellular metabolism/energetics, myocardial remodeling, and genome repair as central contributors to susceptibility.", "sentences": [], "annotations": [], "relations": []}, {"offset": 17603, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "While we cannot say with certainty that the observed association at 1p36.21 is functionally related to PRDM2, there are several features that make it a biologically plausible candidate gene. PRDM2 is critical for BRCA1-dependent repair of DNA double-strand breaks, and impairment of this mechanism exacerbates doxorubicin cardiotoxicity in mice. Additionally, PRDM2 is a transcriptional regulator of heme-oxygenase-1, which, in addition to it's role in protection from oxidative stress, has been shown to facilitate repair of doxorubicin-induced DNA double-strand breaks in vitro and reduce cardiomyocyte apoptosis in doxorubicin-exposed mice.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18249, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "Although the association between rs10443221 and change in LVEF observed in the discovery GWAS was not replicated, CYP2J2 also has biologic plausibility as a candidate gene. CYP2J2 converts arachidonic acid to epoxyeicosatrienoic acids (EETs), whose cardiovascular effects include systemic and coronary vasodilation, anti-inflammatory actions, and promotion of angiogenesis. Exogenous EETs attenuate doxorubicin-induced mitochondrial damage in vitro, and mice with cardiac specific overexpression of human CYP2J2 show reduced cardiomyocyte apoptosis, lower levels of biomarkers of myocardial injury and oxidative stress, and improved cardiac function after exposure to anthracyclines. These functional data may support the measurement of EET's and CYP2J2 function in future studies of anthracycline cardiotoxicity.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19065, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "It was expected that common variants may have cumulative effects on LV function, and that genetic factors contributing smaller effects (OR<=1.5) would be overlooked in the typical single-SNP approach to analysis of GWAS data. Pathway-based analysis identified 18 KEGG pathways associated with change in LV function. DNA injury is an important proximal effect of anthracyclines. Therefore, it is not unexpected that associations with pathways involved in DNA repair. Similarly, the heart has very high energy requirements, and heart failure from any cause, particularly when advanced, is associated with myocardial energy depletion, derangement of mitochondrial function and biogenesis, and a general shift in substrate preference from fatty acids to glucose. The observed associations in energetic pathways may suggest that susceptible individuals have less \"metabolic reserve\" in the face of myocardial injury. Pathway analysis also identified several cellular components and processes previously implicated in myocardial remodeling and response to injury, including glycosylation, constituents of the extracellular matrix (ECM) , and proteins involved in ECM-receptor interaction. Additionally, two important signaling pathways, wnt and notch, also showed evidence for enrichment. The role of both pathways in cancer and metastasis is well established; they are also important for induction of pathologic hypertrophy, cardiac remodeling, and response to various forms of myocardial injury including infarction and pressure overload. The diversity of pathways implicated reinforce the complexity of anthracycline cardiotoxicity and may point toward therapeutic targets.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20741, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "It is interesting that we did not detect associations with many previously implicated susceptibility factors for anthracycline related cardiotoxicity. Difficulty replicating associations between candidate variants and important human phenotypes has been described. It may be that we were underpowered to detect small effect sizes. It is also possible that some published associations are false positives. However, this observation may be related to important differences among studies including population demographics, treatment, comorbidities, follow-up duration, and definition of toxicity.", "sentences": [], "annotations": [], "relations": []}, {"offset": 21335, "infons": {"section_type": "DISCUSS", "type": "paragraph"}, "text": "Results of our study should be interpreted within its limitations. The cohorts used are relatively small, and we were likely underpowered to detect effects of modest size. Additionally, variability in LVEF measurements due to inherent limitations of cardiac imaging and lack of standardized protocols in the discovery cohort (e.g., assessments were clinically indicated and not at pre-specified intervals, contrast was not universally used, LVEF measurements were made using both quantitative and visual estimation methods, and use of different modalities for pre- and post-therapy LVEF determination) could have introduced bias. Finally, we did not perform functional studies to further establish a mechanistic link between the locus tagged by SNP rs7542939 and cardiotoxicity. However, previously published data regarding nearby genes and the availability of an independent replication cohort add confidence to the observed association.", "sentences": [], "annotations": [], "relations": []}, {"offset": 22274, "infons": {"section_type": "CONCL", "type": "title_1"}, "text": "Conclusions", "sentences": [], "annotations": [], "relations": []}, {"offset": 22286, "infons": {"section_type": "CONCL", "type": "paragraph"}, "text": "The genomic architecture of anthracycline cardiotoxicity is complex. Using GWAS we identified a novel susceptibility locus near PRDM2. Pathway analysis suggested that genome repair, metabolism, and pathways relevant for cardiac remodeling influence susceptibility to anthracycline cardiotoxicity. Our findings extend current understanding by identifying a novel risk locus and emphasizing the multifactorial nature of anthracycline cardiotoxicity. This work helps to frame findings from prior candidate studies into a paradigm of genomic injury followed by progressive metabolic and myocardial remodeling. Finally, our findings provide mechanistic insight into anthracycline cardiotoxicity and suggest testable hypotheses for detection and prevention of this adverse effect.", "sentences": [], "annotations": [], "relations": []}, {"offset": 23061, "infons": {"section_type": "SUPPL", "type": "title_1"}, "text": "Supplementary Material", "sentences": [], "annotations": [], "relations": []}, {"offset": 23084, "infons": {"section_type": "SUPPL", "type": "footnote"}, "text": "Conflicts of interest: None declared.", "sentences": [], "annotations": [], "relations": []}, {"offset": 23122, "infons": {"fpage": "e387", "lpage": "96", "name_0": "surname:Shankar;given-names:SM", "name_1": "surname:Marina;given-names:N", "name_2": "surname:Hudson;given-names:MM", "name_3": "surname:Hodgson;given-names:DC", "name_4": "surname:Adams;given-names:MJ", "name_5": "surname:Landier;given-names:W", "pub-id_pmid": "18187811", "section_type": "REF", "source": "PEDIATRICS", "type": "ref", "volume": "121", "year": "2008"}, "text": "Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group", "sentences": [], "annotations": [], "relations": []}, {"offset": 23279, "infons": {"fpage": "404", "lpage": "410", "name_0": "surname:Geisberg;given-names:CA", "name_1": "surname:Sawyer;given-names:DB", "pub-id_pmid": "20842465", "section_type": "REF", "source": "Curr Hypertens Rep", "type": "ref", "volume": "12", "year": "2010"}, "text": "Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage", "sentences": [], "annotations": [], "relations": []}, {"offset": 23364, "infons": {"fpage": "5158", "lpage": "5164", "name_0": "surname:Forrest;given-names:GL", "name_1": "surname:Gonzalez;given-names:B", "name_2": "surname:Tseng;given-names:W", "name_3": "surname:Li;given-names:X", "name_4": "surname:Mann;given-names:J", "pub-id_pmid": "11016643", "section_type": "REF", "source": "Cancer Res", "type": "ref", "volume": "60", "year": "2000"}, "text": "Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice", "sentences": [], "annotations": [], "relations": []}, {"offset": 23499, "infons": {"fpage": "1269", "lpage": "1279", "name_0": "surname:Dell'Acqua;given-names:G", "name_1": "surname:Polishchuck;given-names:R", "name_2": "surname:Fallon;given-names:JT", "name_3": "surname:Gordon;given-names:JW", "pub-id_pmid": "10365658", "section_type": "REF", "source": "Hum Gene Ther", "type": "ref", "volume": "10", "year": "1999"}, "text": "Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain/human multiple drug resistance 1 fusion gene", "sentences": [], "annotations": [], "relations": []}, {"offset": 23646, "infons": {"fpage": "1639", "lpage": "1642", "name_0": "surname:Zhang;given-names:S", "name_1": "surname:Liu;given-names:X", "name_2": "surname:Bawa-Khalfe;given-names:T", "name_3": "surname:Lu;given-names:L-S", "name_4": "surname:Lyu;given-names:YL", "name_5": "surname:Liu;given-names:LF", "section_type": "REF", "source": "Nature Medicine", "type": "ref", "volume": "18", "year": "2012"}, "text": "Identification of the molecular basis of doxorubicin-induced cardiotoxicity", "sentences": [], "annotations": [], "relations": []}, {"offset": 23722, "infons": {"fpage": "4873", "lpage": "4881", "name_0": "surname:Khiati;given-names:S", "name_1": "surname:Dalla Rosa;given-names:I", "name_2": "surname:Sourbier;given-names:C", "name_3": "surname:Ma;given-names:X", "name_4": "surname:Rao;given-names:VA", "name_5": "surname:Neckers;given-names:LM", "pub-id_pmid": "24714774", "section_type": "REF", "source": "Clin Cancer Res", "type": "ref", "volume": "20", "year": "2014"}, "text": "Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity", "sentences": [], "annotations": [], "relations": []}, {"offset": 23818, "infons": {"fpage": "789", "lpage": "797", "name_0": "surname:Abdel-aleem;given-names:S", "name_1": "surname:el-Merzabani;given-names:MM", "name_2": "surname:Sayed-Ahmed;given-names:M", "name_3": "surname:Taylor;given-names:DA", "name_4": "surname:Lowe;given-names:JE", "pub-id_pmid": "9140835", "section_type": "REF", "source": "Journal of molecular and cellular cardiology", "type": "ref", "volume": "29", "year": "1997"}, "text": "Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes", "sentences": [], "annotations": [], "relations": []}, {"offset": 23911, "infons": {"fpage": "3754", "lpage": "3762", "name_0": "surname:Wojnowski;given-names:L", "name_1": "surname:Kulle;given-names:B", "name_2": "surname:Schirmer;given-names:M", "name_3": "surname:Schluter;given-names:G", "name_4": "surname:Schmidt;given-names:A", "name_5": "surname:Rosenberger;given-names:A", "pub-id_pmid": "16330681", "section_type": "REF", "source": "Circulation", "type": "ref", "volume": "112", "year": "2005"}, "text": "NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity", "sentences": [], "annotations": [], "relations": []}, {"offset": 24037, "infons": {"fpage": "1693", "lpage": "1698", "name_0": "surname:Rajic;given-names:V", "name_1": "surname:Aplenc;given-names:R", "name_2": "surname:Debeljak;given-names:M", "name_3": "surname:Prestor;given-names:VV", "name_4": "surname:Karas-Kuzelicki;given-names:N", "name_5": "surname:Mlinaric-Rascan;given-names:I", "pub-id_pmid": "19863340", "section_type": "REF", "source": "Leuk Lymphoma", "type": "ref", "volume": "50", "year": "2009"}, "text": "Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood", "sentences": [], "annotations": [], "relations": []}, {"offset": 24164, "infons": {"fpage": "1415", "lpage": "1421", "name_0": "surname:Blanco;given-names:JG", "name_1": "surname:Sun;given-names:C-L", "name_2": "surname:Landier;given-names:W", "name_3": "surname:Chen;given-names:L", "name_4": "surname:Esparza-Duran;given-names:D", "name_5": "surname:Leisenring;given-names:W", "pub-id_pmid": "22124095", "section_type": "REF", "source": "J Clin Oncol", "type": "ref", "volume": "30", "year": "2012"}, "text": "Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group", "sentences": [], "annotations": [], "relations": []}, {"offset": 24322, "infons": {"fpage": "1422", "lpage": "1428", "name_0": "surname:Visscher;given-names:H", "name_1": "surname:Ross;given-names:CJD", "name_2": "surname:Rassekh;given-names:SR", "name_3": "surname:Barhdadi;given-names:A", "name_4": "surname:Dube;given-names:M-P", "name_5": "surname:Al-Saloos;given-names:H", "pub-id_pmid": "21900104", "section_type": "REF", "source": "J Clin Oncol", "type": "ref", "volume": "30", "year": "2012"}, "text": "Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children", "sentences": [], "annotations": [], "relations": []}, {"offset": 24401, "infons": {"fpage": "231", "name_0": "surname:Lubieniecka;given-names:JM", "name_1": "surname:Graham;given-names:J", "name_2": "surname:Heffner;given-names:D", "name_3": "surname:Mottus;given-names:R", "name_4": "surname:Reid;given-names:R", "name_5": "surname:Hogge;given-names:D", "pub-id_pmid": "24273552", "section_type": "REF", "source": "Frontiers in Genetics", "type": "ref", "volume": "4", "year": "2013"}, "text": "A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor", "sentences": [], "annotations": [], "relations": []}, {"offset": 24578, "infons": {"fpage": "1079", "lpage": "1084", "name_0": "surname:Aminkeng;given-names:F", "name_1": "surname:Bhavsar;given-names:AP", "name_2": "surname:Visscher;given-names:H", "name_3": "surname:Rassekh;given-names:SR", "name_4": "surname:Li;given-names:Y", "name_5": "surname:Lee;given-names:JW", "pub-id_pmid": "26237429", "section_type": "REF", "source": "Nat Genet", "type": "ref", "volume": "47", "year": "2015"}, "text": "A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 24686, "infons": {"fpage": "168", "lpage": "178", "name_0": "surname:Vasan;given-names:RS", "name_1": "surname:Glazer;given-names:NL", "name_2": "surname:Felix;given-names:JF", "name_3": "surname:Lieb;given-names:W", "name_4": "surname:Wild;given-names:PS", "name_5": "surname:Felix;given-names:SB", "pub-id_pmid": "19584346", "section_type": "REF", "source": "JAMA", "type": "ref", "volume": "302", "year": "2009"}, "text": "Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data", "sentences": [], "annotations": [], "relations": []}, {"offset": 24815, "infons": {"fpage": "1981", "lpage": "1988", "name_0": "surname:Cardinale;given-names:D", "name_1": "surname:Colombo;given-names:A", "name_2": "surname:Bacchiani;given-names:G", "name_3": "surname:Tedeschi;given-names:I", "name_4": "surname:Meroni;given-names:CA", "name_5": "surname:Veglia;given-names:F", "pub-id_pmid": "25948538", "section_type": "REF", "source": "Circulation", "type": "ref", "volume": "131", "year": "2015"}, "text": "Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy", "sentences": [], "annotations": [], "relations": []}, {"offset": 24906, "infons": {"fpage": "362", "lpage": "369", "name_0": "surname:Roden;given-names:DM", "name_1": "surname:Pulley;given-names:JM", "name_2": "surname:Basford;given-names:MA", "name_3": "surname:Bernard;given-names:GR", "name_4": "surname:Clayton;given-names:EW", "name_5": "surname:Balser;given-names:JR", "pub-id_pmid": "18500243", "section_type": "REF", "source": "Clinical Pharmacology & Therapeutics", "type": "ref", "volume": "84", "year": "2008"}, "text": "Development of a large-scale de-identified DNA biobank to enable personalized medicine", "sentences": [], "annotations": [], "relations": []}, {"offset": 24993, "infons": {"fpage": "234cm3", "lpage": "234cm3", "name_0": "surname:Bowton;given-names:E", "name_1": "surname:Field;given-names:JR", "name_2": "surname:Wang;given-names:S", "name_3": "surname:Schildcrout;given-names:JS", "name_4": "surname:Van Driest;given-names:SL", "name_5": "surname:Delaney;given-names:JT", "section_type": "REF", "source": "Sci Transl Med", "type": "ref", "volume": "6", "year": "2014"}, "text": "Biobanks and electronic medical records: enabling cost-effective research", "sentences": [], "annotations": [], "relations": []}, {"offset": 25067, "infons": {"name_0": "surname:Altman;given-names:AJ", "section_type": "REF", "source": "Supportive Care of Children with Cancer", "type": "ref", "year": "2004"}, "text": "", "sentences": [], "annotations": [], "relations": []}, {"offset": 25068, "infons": {"fpage": "e1000529", "name_0": "surname:Howie;given-names:BN", "name_1": "surname:Donnelly;given-names:P", "name_2": "surname:Marchini;given-names:J", "pub-id_pmid": "19543373", "section_type": "REF", "source": "PLoS Genet", "type": "ref", "volume": "5", "year": "2009"}, "text": "A flexible and accurate genotype imputation method for the next generation of genome-wide association studies", "sentences": [], "annotations": [], "relations": []}, {"offset": 25178, "infons": {"fpage": "563", "lpage": "571", "name_0": "surname:Yaspan;given-names:BL", "name_1": "surname:Bush;given-names:WS", "name_2": "surname:Torstenson;given-names:ES", "name_3": "surname:Ma;given-names:D", "name_4": "surname:Pericak-Vance;given-names:MA", "name_5": "surname:Ritchie;given-names:MD", "pub-id_pmid": "21279722", "section_type": "REF", "source": "Hum Genet", "type": "ref", "volume": "129", "year": "2011"}, "text": "Genetic analysis of biological pathway data through genomic randomization", "sentences": [], "annotations": [], "relations": []}, {"offset": 25252, "infons": {"fpage": "27", "lpage": "30", "name_0": "surname:Kanehisa;given-names:M", "name_1": "surname:Goto;given-names:S", "pub-id_pmid": "10592173", "section_type": "REF", "source": "Nucleic Acids Res", "type": "ref", "volume": "28", "year": "2000"}, "text": "KEGG: kyoto encyclopedia of genes and genomes", "sentences": [], "annotations": [], "relations": []}, {"offset": 25298, "infons": {"fpage": "7619", "lpage": "7623", "name_0": "surname:Kim;given-names:K-C", "name_1": "surname:Geng;given-names:L", "name_2": "surname:Huang;given-names:S", "pub-id_pmid": "14633678", "section_type": "REF", "source": "Cancer Res", "type": "ref", "volume": "63", "year": "2003"}, "text": "Inactivation of a histone methyltransferase by mutations in human cancers", "sentences": [], "annotations": [], "relations": []}, {"offset": 25372, "infons": {"fpage": "1049", "lpage": "1062", "name_0": "surname:Khurana;given-names:S", "name_1": "surname:Kruhlak;given-names:MJ", "name_2": "surname:Kim;given-names:J", "name_3": "surname:Tran;given-names:AD", "name_4": "surname:Liu;given-names:J", "name_5": "surname:Nyswaner;given-names:K", "section_type": "REF", "source": "CellReports", "type": "ref", "volume": "8", "year": "2014"}, "text": "A Macrohistone Variant Links Dynamic Chromatin Compaction to BRCA1-Dependent Genome Maintenance", "sentences": [], "annotations": [], "relations": []}, {"offset": 25468, "infons": {"fpage": "593", "name_0": "surname:Shukla;given-names:PC", "name_1": "surname:Singh;given-names:KK", "name_2": "surname:Quan;given-names:A", "name_3": "surname:Al-Omran;given-names:M", "name_4": "surname:Teoh;given-names:H", "name_5": "surname:Lovren;given-names:F", "section_type": "REF", "source": "Nature Communications", "type": "ref", "volume": "2", "year": "2011"}, "text": "BRCA1 is an essential regulator of heart function and survival following myocardial infarction", "sentences": [], "annotations": [], "relations": []}, {"offset": 25563, "infons": {"fpage": "471", "lpage": "479", "name_0": "surname:Muraosa;given-names:Y", "name_1": "surname:Takahashi;given-names:K", "name_2": "surname:Yoshizawa;given-names:M", "name_3": "surname:Shibahara;given-names:S", "pub-id_pmid": "8654390", "section_type": "REF", "source": "Eur J Biochem", "type": "ref", "volume": "235", "year": "1996"}, "text": "cDNA cloning of a novel protein containing two zinc-finger domains that may function as a transcription factor for the human heme-oxygenase-1 gene", "sentences": [], "annotations": [], "relations": []}, {"offset": 25710, "infons": {"fpage": "9", "lpage": "19", "name_0": "surname:Choi;given-names:AM", "name_1": "surname:Alam;given-names:J", "pub-id_pmid": "8679227", "section_type": "REF", "source": "Am J Respir Cell Mol Biol", "type": "ref", "volume": "15", "year": "1996"}, "text": "Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury", "sentences": [], "annotations": [], "relations": []}, {"offset": 25833, "infons": {"fpage": "L688", "lpage": "94", "name_0": "surname:Otterbein;given-names:LE", "name_1": "surname:Mantell;given-names:LL", "name_2": "surname:Choi;given-names:AM", "pub-id_pmid": "10198367", "section_type": "REF", "source": "Am J Physiol", "type": "ref", "volume": "276", "year": "1999"}, "text": "Carbon monoxide provides protection against hyperoxic lung injury", "sentences": [], "annotations": [], "relations": []}, {"offset": 25899, "infons": {"fpage": "14491", "lpage": "14496", "name_0": "surname:Otterbein;given-names:LE", "name_1": "surname:Hedblom;given-names:A", "name_2": "surname:Harris;given-names:C", "name_3": "surname:Csizmadia;given-names:E", "name_4": "surname:Gallo;given-names:D", "name_5": "surname:Wegiel;given-names:B", "section_type": "REF", "source": "Proceedings of the National Academy of Sciences", "type": "ref", "volume": "108", "year": "2011"}, "text": "Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein", "sentences": [], "annotations": [], "relations": []}, {"offset": 26008, "infons": {"fpage": "341", "lpage": "349", "name_0": "surname:Gu;given-names:J", "name_1": "surname:Song;given-names:Z-P", "name_2": "surname:Gui;given-names:D-M", "name_3": "surname:Hu;given-names:W", "name_4": "surname:Chen;given-names:Y-G", "name_5": "surname:Zhang;given-names:D-D", "pub-id_pmid": "22763982", "section_type": "REF", "source": "Cardiovasc Toxicol", "type": "ref", "volume": "12", "year": "2012"}, "text": "Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in lymphoma nude mice by heme oxygenase-1 induction", "sentences": [], "annotations": [], "relations": []}, {"offset": 26127, "infons": {"fpage": "769", "lpage": "776", "name_0": "surname:Archer;given-names:SL", "name_1": "surname:Gragasin;given-names:FS", "name_2": "surname:Wu;given-names:X", "name_3": "surname:Wang;given-names:S", "name_4": "surname:McMurtry;given-names:S", "name_5": "surname:Kim;given-names:DH", "pub-id_pmid": "12578883", "section_type": "REF", "source": "Circulation", "type": "ref", "volume": "107", "year": "2003"}, "text": "Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels", "sentences": [], "annotations": [], "relations": []}, {"offset": 26303, "infons": {"fpage": "1276", "lpage": "1279", "name_0": "surname:Node;given-names:K", "name_1": "surname:Huo;given-names:Y", "name_2": "surname:Ruan;given-names:X", "name_3": "surname:Yang;given-names:B", "name_4": "surname:Spiecker;given-names:M", "name_5": "surname:Ley;given-names:K", "pub-id_pmid": "10455056", "section_type": "REF", "source": "Science", "type": "ref", "volume": "285", "year": "1999"}, "text": "Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids", "sentences": [], "annotations": [], "relations": []}, {"offset": 26383, "infons": {"fpage": "60", "lpage": "67", "name_0": "surname:Fleming;given-names:I", "pub-id_pmid": "17164133", "section_type": "REF", "source": "Prostaglandins Other Lipid Mediat", "type": "ref", "volume": "82", "year": "2007"}, "text": "Epoxyeicosatrienoic acids, cell signaling and angiogenesis", "sentences": [], "annotations": [], "relations": []}, {"offset": 26442, "infons": {"fpage": "H37", "lpage": "46", "name_0": "surname:Zhang;given-names:Y", "name_1": "surname:El-Sikhry;given-names:H", "name_2": "surname:Chaudhary;given-names:KR", "name_3": "surname:Batchu;given-names:SN", "name_4": "surname:Shayeganpour;given-names:A", "name_5": "surname:Jukar;given-names:TO", "pub-id_pmid": "19429816", "section_type": "REF", "source": "Am J Physiol Heart Circ Physiol", "type": "ref", "volume": "297", "year": "2009"}, "text": "Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity", "sentences": [], "annotations": [], "relations": []}, {"offset": 26530, "infons": {"fpage": "1267", "lpage": "1274", "name_0": "surname:Beer;given-names:M", "name_1": "surname:Seyfarth;given-names:T", "name_2": "surname:Sandstede;given-names:J", "name_3": "surname:Landschutz;given-names:W", "name_4": "surname:Lipke;given-names:C", "name_5": "surname:Kostler;given-names:H", "section_type": "REF", "source": "JAC", "type": "ref", "volume": "40", "year": "2002"}, "text": "Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy", "sentences": [], "annotations": [], "relations": []}, {"offset": 26718, "infons": {"fpage": "461", "lpage": "470", "name_0": "surname:Doenst;given-names:T", "name_1": "surname:Pytel;given-names:G", "name_2": "surname:Schrepper;given-names:A", "name_3": "surname:Amorim;given-names:P", "name_4": "surname:Farber;given-names:G", "name_5": "surname:Shingu;given-names:Y", "pub-id_pmid": "20035032", "section_type": "REF", "source": "Cardiovascular Research", "type": "ref", "volume": "86", "year": "2010"}, "text": "Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload", "sentences": [], "annotations": [], "relations": []}, {"offset": 26859, "infons": {"fpage": "20", "lpage": "12", "name_0": "surname:Liddy;given-names:KA", "name_1": "surname:White;given-names:MY", "name_2": "surname:Cordwell;given-names:SJ", "pub-id_pmid": "23445784", "section_type": "REF", "source": "Genome Medicine", "type": "ref", "volume": "5", "year": "2013"}, "text": "Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics", "sentences": [], "annotations": [], "relations": []}, {"offset": 26968, "infons": {"fpage": "M110.006833", "lpage": "M110.006833", "name_0": "surname:Parker;given-names:BL", "name_1": "surname:Palmisano;given-names:G", "name_2": "surname:Edwards;given-names:AVG", "name_3": "surname:White;given-names:MY", "name_4": "surname:Engholm-Keller;given-names:K", "name_5": "surname:Lee;given-names:A", "section_type": "REF", "source": "Mol Cell Proteomics", "type": "ref", "volume": "10", "year": "2011"}, "text": "Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment", "sentences": [], "annotations": [], "relations": []}, {"offset": 27110, "infons": {"fpage": "147", "lpage": "157", "name_0": "surname:Koitabashi;given-names:N", "name_1": "surname:Kass;given-names:DA", "section_type": "REF", "source": "Nat Rev Cardiol", "type": "ref", "volume": "9", "year": "2012"}, "text": "Reverse remodeling in heart failure--mechanisms and therapeutic opportunities", "sentences": [], "annotations": [], "relations": []}, {"offset": 27188, "infons": {"fpage": "83", "lpage": "16", "name_0": "surname:Chakravarti;given-names:R", "name_1": "surname:Adams;given-names:JC", "pub-id_pmid": "16620374", "section_type": "REF", "source": "BMC Genomics", "type": "ref", "volume": "7", "year": "2006"}, "text": "Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates", "sentences": [], "annotations": [], "relations": []}, {"offset": 27304, "infons": {"fpage": "301", "lpage": "308", "name_0": "surname:Finsen;given-names:AV", "name_1": "surname:Woldbaek;given-names:PR", "name_2": "surname:Li;given-names:J", "name_3": "surname:Wu;given-names:J", "name_4": "surname:Lyberg;given-names:T", "name_5": "surname:Tonnessen;given-names:T", "pub-id_pmid": "14625378", "section_type": "REF", "source": "Physiol Genomics", "type": "ref", "volume": "16", "year": "2004"}, "text": "Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling", "sentences": [], "annotations": [], "relations": []}, {"offset": 27405, "infons": {"fpage": "318", "lpage": "328", "name_0": "surname:van Almen;given-names:GC", "name_1": "surname:Swinnen;given-names:M", "name_2": "surname:Carai;given-names:P", "name_3": "surname:Verhesen;given-names:W", "name_4": "surname:Cleutjens;given-names:JPM", "name_5": "surname:D'hooge;given-names:J", "pub-id_pmid": "21624372", "section_type": "REF", "source": "Journal of molecular and cellular cardiology", "type": "ref", "volume": "51", "year": "2011"}, "text": "Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy", "sentences": [], "annotations": [], "relations": []}, {"offset": 27524, "infons": {"fpage": "186", "lpage": "198", "name_0": "surname:Hu;given-names:Y-Y", "name_1": "surname:Zheng;given-names:M-H", "name_2": "surname:Zhang;given-names:R", "name_3": "surname:Liang;given-names:Y-M", "name_4": "surname:Han;given-names:H", "pub-id_pmid": "22399348", "section_type": "REF", "source": "Adv Exp Med Biol", "type": "ref", "volume": "727", "year": "2012"}, "text": "Notch signaling pathway and cancer metastasis", "sentences": [], "annotations": [], "relations": []}, {"offset": 27570, "infons": {"fpage": "387", "lpage": "398", "name_0": "surname:Klaus;given-names:A", "name_1": "surname:Birchmeier;given-names:W", "pub-id_pmid": "18432252", "section_type": "REF", "source": "Nat Rev Cancer", "type": "ref", "volume": "8", "year": "2008"}, "text": "Wnt signalling and its impact on development and cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 27626, "infons": {"fpage": "3173", "lpage": "3185", "name_0": "surname:Croquelois;given-names:A", "name_1": "surname:Domenighetti;given-names:AA", "name_2": "surname:Nemir;given-names:M", "name_3": "surname:Lepore;given-names:M", "name_4": "surname:Rosenblatt-Velin;given-names:N", "name_5": "surname:Radtke;given-names:F", "pub-id_pmid": "19064701", "section_type": "REF", "source": "J Exp Med", "type": "ref", "volume": "205", "year": "2008"}, "text": "Control of the adaptive response of the heart to stress via the Notch1 receptor pathway", "sentences": [], "annotations": [], "relations": []}, {"offset": 27714, "infons": {"fpage": "142", "lpage": "151", "name_0": "surname:You;given-names:J", "name_1": "surname:Wu;given-names:J", "name_2": "surname:Jiang;given-names:G", "name_3": "surname:Guo;given-names:J", "name_4": "surname:Wang;given-names:S", "name_5": "surname:Li;given-names:L", "pub-id_pmid": "23188126", "section_type": "REF", "source": "Journal of Cardiovascular Pharmacology", "type": "ref", "volume": "61", "year": "2013"}, "text": "Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice", "sentences": [], "annotations": [], "relations": []}, {"offset": 27820, "infons": {"fpage": "228", "lpage": "231", "name_0": "surname:Li;given-names:Y", "name_1": "surname:Hiroi;given-names:Y", "name_2": "surname:Liao;given-names:JK", "pub-id_pmid": "22293023", "section_type": "REF", "source": "Trends Cardiovasc Med", "type": "ref", "volume": "20", "year": "2010"}, "text": "Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction", "sentences": [], "annotations": [], "relations": []}, {"offset": 27924, "infons": {"fpage": "939", "lpage": "945", "name_0": "surname:Malekar;given-names:P", "name_1": "surname:Hagenmueller;given-names:M", "name_2": "surname:Anyanwu;given-names:A", "name_3": "surname:Buss;given-names:S", "name_4": "surname:Streit;given-names:MR", "name_5": "surname:Weiss;given-names:CS", "pub-id_pmid": "20177000", "section_type": "REF", "source": "Hypertension", "type": "ref", "volume": "55", "year": "2010"}, "text": "Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling", "sentences": [], "annotations": [], "relations": []}, {"offset": 28024, "infons": {"fpage": "1198", "lpage": "1208", "name_0": "surname:Bergmann;given-names:MW", "pub-id_pmid": "21071717", "section_type": "REF", "source": "Circulation Research", "type": "ref", "volume": "107", "year": "2010"}, "text": "WNT Signaling in Adult Cardiac Hypertrophy and Remodeling: Lessons Learned From Cardiac Development", "sentences": [], "annotations": [], "relations": []}, {"offset": 28124, "infons": {"fpage": "129", "lpage": "134", "name_0": "surname:Deng;given-names:S", "name_1": "surname:Wojnowski;given-names:L", "pub-id_pmid": "17652817", "section_type": "REF", "source": "Cardiovasc Toxicol", "type": "ref", "volume": "7", "year": "2007"}, "text": "Genotyping the risk of anthracycline-induced cardiotoxicity", "sentences": [], "annotations": [], "relations": []}, {"offset": 28184, "infons": {"fpage": "306", "lpage": "309", "name_0": "surname:Ioannidis;given-names:JP", "name_1": "surname:Ntzani;given-names:EE", "name_2": "surname:Trikalinos;given-names:TA", "name_3": "surname:Contopoulos-Ioannidis;given-names:DG", "pub-id_pmid": "11600885", "section_type": "REF", "source": "Nat Genet", "type": "ref", "volume": "29", "year": "2001"}, "text": "Replication validity of genetic association studies", "sentences": [], "annotations": [], "relations": []}, {"offset": 28236, "infons": {"file": "nihms870773f1.jpg", "id": "F1", "section_type": "FIG", "type": "fig_caption"}, "text": "Change in ejection fraction from baseline in discovery GWAS and replication cohorts. In each panel, total doxorubicin equivalents per square meter (mg/m2) are shown on the X-axis, and change in left ventricular ejection fraction (LVEF) on the Y-axis. A) Discovery GWAS cohort. B) Replication cohort", "sentences": [], "annotations": [], "relations": []}, {"offset": 28535, "infons": {"file": "nihms870773f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "Manhattan plot of discovery GWAS of change in left ventricular ejection fraction (LVEF). Results for each variant are organized according to chromosomal position on the X-axis, with -log10 (p-values) for association of genotype to change LVEF from the discovery cohort on the Y-axis. The horizontal line indicates the a priori threshold for statistical significance.", "sentences": [], "annotations": [], "relations": []}, {"offset": 28902, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table_caption"}, "text": "Demographics for Discovery GWAS Cohort (N=385)", "sentences": [], "annotations": [], "relations": []}, {"offset": 28949, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"above\" rules=\"groups\">\n        <thead>\n          <tr>\n            <th valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Parameter</th>\n            <th valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">N (Percent) or Median (IQR)</th>\n          </tr>\n        </thead>\n        <tbody>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Female</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">223 (58%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Age at Start of Chemotherapy (years)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">52 (40 to 61)</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\">Race</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> White</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">337 (88%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Black</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">30 (8%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Asian</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1 (0.3%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Latino</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">4 (1%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Unknown</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">13 (3%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Baseline Ejection Fraction (%)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">64 (60 to 68)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Time from Chemotherapy to Outcome LVEF<xref rid=\"TFN1\" ref-type=\"table-fn\">*</xref> (days)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">348 (122 to 755)</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\">Most Frequent Oncologic Diagnosis</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Non-Hodgkin Lymphoma</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">109 (28%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Breast cancer</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">78 (20%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> AML</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">59 (15%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Sarcoma</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">39 (10%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Hodgkin Lymphoma</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">28 (7%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Radiation to Chest</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">71 (18%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Cumulative Anthracycline Dose (Doxorubicin equiv. mg/m<sup>2</sup>)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">240 (180 to 300)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Change in LVEF</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-6 (0 to -12) (range 22 to -47)</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\">Cardiovascular Risk Factors</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Hypertension</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">139 (36%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Dyslipidemia</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">76 (20%)</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\"> Smoking</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">  Never</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">228 (59%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">  Former</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">81 (21%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">  Current</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">76 (20%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Diabetes</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">39 (10%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Coronary artery disease</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">19 (5%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">BMI<xref rid=\"TFN2\" ref-type=\"table-fn\"> </xref> (kg/m<sup>2</sup>)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">28 (24 to 32)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Trastuzumab</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">26 (7%)</td>\n          </tr>\n        </tbody>\n      </table>\n"}, "text": "Parameter\tN (Percent) or Median (IQR)\t \tFemale\t223 (58%)\t \tAge at Start of Chemotherapy (years)\t52 (40 to 61)\t \tRace\t \t White\t337 (88%)\t \t Black\t30 (8%)\t \t Asian\t1 (0.3%)\t \t Latino\t4 (1%)\t \t Unknown\t13 (3%)\t \tBaseline Ejection Fraction (%)\t64 (60 to 68)\t \tTime from Chemotherapy to Outcome LVEF* (days)\t348 (122 to 755)\t \tMost Frequent Oncologic Diagnosis\t \t Non-Hodgkin Lymphoma\t109 (28%)\t \t Breast cancer\t78 (20%)\t \t AML\t59 (15%)\t \t Sarcoma\t39 (10%)\t \t Hodgkin Lymphoma\t28 (7%)\t \tRadiation to Chest\t71 (18%)\t \tCumulative Anthracycline Dose (Doxorubicin equiv. mg/m2)\t240 (180 to 300)\t \tChange in LVEF\t-6 (0 to -12) (range 22 to -47)\t \tCardiovascular Risk Factors\t \t Hypertension\t139 (36%)\t \t Dyslipidemia\t76 (20%)\t \t Smoking\t \t  Never\t228 (59%)\t \t  Former\t81 (21%)\t \t  Current\t76 (20%)\t \t Diabetes\t39 (10%)\t \t Coronary artery disease\t19 (5%)\t \tBMI  (kg/m2)\t28 (24 to 32)\t \tTrastuzumab\t26 (7%)\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 29897, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table_footnote"}, "text": "LVEF = Left ventricular ejection fraction;", "sentences": [], "annotations": [], "relations": []}, {"offset": 29940, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table_footnote"}, "text": "BMI = Body mass index", "sentences": [], "annotations": [], "relations": []}, {"offset": 29962, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_caption"}, "text": "Demographics for Replication Cohort (N=181)", "sentences": [], "annotations": [], "relations": []}, {"offset": 30006, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\">\n        <thead>\n          <tr>\n            <th valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Parameter</th>\n            <th valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Percent (N) or Median (IQR)</th>\n          </tr>\n        </thead>\n        <tbody>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Female</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">158 (87%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Age at Start of Chemotherapy (years)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">53 (45 to 61)</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\">Race</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> White</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">152 (84%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Black</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">23 (13%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Asian</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3 (2%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Unknown</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3 (2%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Baseline LVEF (%)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">64 (60 to 68)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Time from Baseline LVEF to Anthracycline<xref rid=\"TFN3\" ref-type=\"table-fn\">*</xref> (days)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">6 (2 to 13 days)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Time from Chemotherapy to Outcome LVEF (days)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">217 (180 to 364)</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\">Oncologic Diagnosis</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Breast cancer</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">145 (80%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Lymphoma</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">32 (18%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Gastrointestinal</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3 (2%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Sarcoma</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1 (0.6%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Radiation to Chest</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Not available</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Cumulative Anthracycline Dose (Doxorubicin equiv. mg/m<sup>2</sup>)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">224 (60 to 241)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Change in Ejection Fraction (%)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-4 (3 to -9) [range 16 to -28]</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\">Cardiovascular Risk Factors</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Hypertension</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">61 (34%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Dyslipidemia</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">55 (30%)</td>\n          </tr>\n          <tr>\n            <td colspan=\"2\" align=\"left\" valign=\"top\" rowspan=\"1\"> Smoking</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">  Never</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">106 (59%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">  Former</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">48 (27%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">  Current</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">27 (15%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Diabetes</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">25 (14%)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"> Coronary artery disease</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Not available</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">BMI<xref rid=\"TFN4\" ref-type=\"table-fn\"> </xref> (kg/m<sup>2</sup>)</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">29 (25-34)</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Trastuzumab</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">25 (14%)</td>\n          </tr>\n        </tbody>\n      </table>\n"}, "text": "Parameter\tPercent (N) or Median (IQR)\t \tFemale\t158 (87%)\t \tAge at Start of Chemotherapy (years)\t53 (45 to 61)\t \tRace\t \t White\t152 (84%)\t \t Black\t23 (13%)\t \t Asian\t3 (2%)\t \t Unknown\t3 (2%)\t \tBaseline LVEF (%)\t64 (60 to 68)\t \tTime from Baseline LVEF to Anthracycline* (days)\t6 (2 to 13 days)\t \tTime from Chemotherapy to Outcome LVEF (days)\t217 (180 to 364)\t \tOncologic Diagnosis\t \t Breast cancer\t145 (80%)\t \t Lymphoma\t32 (18%)\t \t Gastrointestinal\t3 (2%)\t \t Sarcoma\t1 (0.6%)\t \tRadiation to Chest\tNot available\t \tCumulative Anthracycline Dose (Doxorubicin equiv. mg/m2)\t224 (60 to 241)\t \tChange in Ejection Fraction (%)\t-4 (3 to -9) [range 16 to -28]\t \tCardiovascular Risk Factors\t \t Hypertension\t61 (34%)\t \t Dyslipidemia\t55 (30%)\t \t Smoking\t \t  Never\t106 (59%)\t \t  Former\t48 (27%)\t \t  Current\t27 (15%)\t \t Diabetes\t25 (14%)\t \t Coronary artery disease\tNot available\t \tBMI  (kg/m2)\t29 (25-34)\t \tTrastuzumab\t25 (14%)\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 30967, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_footnote"}, "text": "LVEF = Left ventricular ejection fraction;", "sentences": [], "annotations": [], "relations": []}, {"offset": 31010, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_footnote"}, "text": "BMI = Body mass index", "sentences": [], "annotations": [], "relations": []}, {"offset": 31032, "infons": {"file": "T3.xml", "id": "T3", "section_type": "TABLE", "type": "table_caption"}, "text": "Results of Association Testing for Discovery and Replication Cohorts", "sentences": [], "annotations": [], "relations": []}, {"offset": 31101, "infons": {"file": "T3.xml", "id": "T3", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"box\" rules=\"all\">\n        <thead>\n          <tr>\n            <th colspan=\"4\" valign=\"top\" align=\"center\" rowspan=\"1\">Locus Details</th>\n            <th colspan=\"3\" valign=\"top\" align=\"center\" rowspan=\"1\">Discovery GWAS</th>\n            <th colspan=\"3\" valign=\"top\" align=\"center\" rowspan=\"1\">Replication</th>\n          </tr>\n          <tr>\n            <th valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Locus</th>\n            <th valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">SNP</th>\n            <th valign=\"top\" align=\"left\" rowspan=\"1\" colspan=\"1\">Nearest Annotated Gene(s)</th>\n            <th valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">Coded Allele</th>\n            <th valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">MAF</th>\n            <th valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">Beta (SE)</th>\n            <th valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">p-value</th>\n            <th valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">MAF</th>\n            <th valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">Beta (SE)</th>\n            <th valign=\"top\" align=\"center\" rowspan=\"1\" colspan=\"1\">p-value</th>\n          </tr>\n        </thead>\n        <tbody>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1p32.1</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs10443221</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">HOOK1, CYP2J2, C1orf187</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">T</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.38</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">4.11 (0.74)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">2.7 e-8</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.34</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-1.2 (0.80)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.14</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1p36.21</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs7542939</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">PRDM2</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">A</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.15</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-4.97 (1.10)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">5.9 e-6</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.14</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-2.7 (1.08)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.01</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">2p12</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs78000710</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">LRRTM4</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">C</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.07</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-6.60 (1.52)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1.4 e-5</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.08</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-0.12 (1.50)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.94</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3q28</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs7635904</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">TPRG1</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">G</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.08</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-5.82 (1.28)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">5.3 e-6</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.12</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-0.85 (1.17)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.47</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">6p21.1</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs990963</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">LRRTM4</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">C</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.39</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-3.47 (0.78)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">7.8 e-6</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.39</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-0.18 (0.79)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.82</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">7p21.1</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs7801891</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">AHR, AGR3</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">C</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.08</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">6.21 (1.33)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3.0 e-6</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.06</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.33 (1.50)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.83</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">12q24.13</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs11066861</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">RBM19</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">A</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.06</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-7.10 (1.58)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">7.1 e-6</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.06</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1.18 (1.64)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.47</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">13q31.3</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs34223702</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">LINC00379</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">A</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.06</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-8.32 (1.72)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1.4 e-6</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.07</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-1.11 (1.45)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.45</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">15q13.1</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs7179489</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">FAM189A1</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">A</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.41</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3.29 (0.75)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1.3 e-5</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.40</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.22 (0.78)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.77</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">16q24.1</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs55669225</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">LINC00917</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">A</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.07</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-6.51 (1.47)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">9.3 e-6</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.06</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-0.86 (1.69)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.61</td>\n          </tr>\n          <tr>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">19q12</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">rs12984615</td>\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">URI1</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">A</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.49</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-3.22 (0.77)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3.0 e-5</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.51</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">-1.30 (0.73)</td>\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">0.08</td>\n          </tr>\n        </tbody>\n      </table>\n"}, "text": "Locus Details\tDiscovery GWAS\tReplication\t \tLocus\tSNP\tNearest Annotated Gene(s)\tCoded Allele\tMAF\tBeta (SE)\tp-value\tMAF\tBeta (SE)\tp-value\t \t1p32.1\trs10443221\tHOOK1, CYP2J2, C1orf187\tT\t0.38\t4.11 (0.74)\t2.7 e-8\t0.34\t-1.2 (0.80)\t0.14\t \t1p36.21\trs7542939\tPRDM2\tA\t0.15\t-4.97 (1.10)\t5.9 e-6\t0.14\t-2.7 (1.08)\t0.01\t \t2p12\trs78000710\tLRRTM4\tC\t0.07\t-6.60 (1.52)\t1.4 e-5\t0.08\t-0.12 (1.50)\t0.94\t \t3q28\trs7635904\tTPRG1\tG\t0.08\t-5.82 (1.28)\t5.3 e-6\t0.12\t-0.85 (1.17)\t0.47\t \t6p21.1\trs990963\tLRRTM4\tC\t0.39\t-3.47 (0.78)\t7.8 e-6\t0.39\t-0.18 (0.79)\t0.82\t \t7p21.1\trs7801891\tAHR, AGR3\tC\t0.08\t6.21 (1.33)\t3.0 e-6\t0.06\t0.33 (1.50)\t0.83\t \t12q24.13\trs11066861\tRBM19\tA\t0.06\t-7.10 (1.58)\t7.1 e-6\t0.06\t1.18 (1.64)\t0.47\t \t13q31.3\trs34223702\tLINC00379\tA\t0.06\t-8.32 (1.72)\t1.4 e-6\t0.07\t-1.11 (1.45)\t0.45\t \t15q13.1\trs7179489\tFAM189A1\tA\t0.41\t3.29 (0.75)\t1.3 e-5\t0.40\t0.22 (0.78)\t0.77\t \t16q24.1\trs55669225\tLINC00917\tA\t0.07\t-6.51 (1.47)\t9.3 e-6\t0.06\t-0.86 (1.69)\t0.61\t \t19q12\trs12984615\tURI1\tA\t0.49\t-3.22 (0.77)\t3.0 e-5\t0.51\t-1.30 (0.73)\t0.08\t \t", "sentences": [], "annotations": [], "relations": []}], "annotations": [], "relations": []}]}